Dechra Pharmaceuticals Reports 4.7% Revenue Rise In Third Quarter
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Wednesday said it has seen its revenue rise in the third quarter to end-March, seeing a strong performance from both its European and US operations. Total revenues were 4.7% ahead of the previous year, and 4.9% on a constant currency basis Read More